Certified by Founder Lodge
TRexBio
United States - South San Francisco, California
START UP
1 Disclosed Funding Rounds $84,000,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
TRexBio is a discovery stage biotechnology company leveraging cutting edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop revolutionary therap
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 14 ,2024 | Series B | $84,000,000 |
Johnson & Johnson
Eli Lilly and Company
Polaris Partners
SV Health Investors
Pfizer
Agent Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Prelude(FRANCE) | $8,000,000 | (Nov 14, 2024)
CHAOS Industries | $145,000,000 | (Nov 14, 2024)
Camouflet | $3,000,000 | (Nov 14, 2024)
Zeplyn | $3,000,000 | (Nov 14, 2024)
Notabene | $14,500,000 | (Nov 14, 2024)
